A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)

Name: A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)
Published: 2008
License: Public Domain

Abbott · 2008

ClinicalTrials.gov · Datasets · License: Public Domain · 2008

Open Source ↗

cancer carcinoma non-small-cell-lung-cancer

non-small cell lung cancer, cancer, carcinoma, monoclonal antibody therapy, anti-angiogenesis, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)

Related documents